Dr. Joshua A. Hill

Claim this profile

Fred Hutch/University of Washington Cancer Consortium

Studies Lymphoma
Studies B-Cell Lymphoma
3 reported clinical trials
4 drugs studied

Affiliated Hospitals

Image of trial facility.
Fred Hutch/University Of Washington Cancer Consortium

Clinical Trials Joshua A. Hill is currently running

Image of trial facility.

IVIG

for Infection Prevention After Lymphoma Treatment

This phase II trial compares the effects of immunoglobulin replacement therapy with a placebo for preventing infectious complications in patients receiving CD19 chimeric antigen receptor (CAR)-T cell therapy. Hypogammaglobulinemia is a common complication in patients who receive CD19 CAR-T cell therapy. This is a condition in which the level of immunoglobulins (antibodies) in the blood is low and the risk of infection is high. Immunoglobulin replacement therapy works by replacing the body's immunoglobulin G (IgG) antibodies with donor blood product derived IgG antibodies that may help prevent infection. IgG antibodies are often depleted as a result of CAR-T therapy. Giving immunoglobulin replacement therapy may prevent infectious complications in patients receiving CD19 CAR-T cell therapy.
Recruiting0 awards Phase 2

More about Joshua A. Hill

Clinical Trial Related1 year of experience running clinical trials · Led 3 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Joshua A. Hill has experience with
  • Anti-CD19-targeting CAR-T Cells
  • Immune Globulin Infusion (Human), 10% Solution
  • Wistar Rabies Virus Strain PM-1503-3M Vaccine
  • Remdesivir
Breakdown of trials Joshua A. Hill has run
Lymphoma
B-Cell Lymphoma
Infections and Infestations
Multiple Myeloma
Cancer

Other Doctors you might be interested in

Stephen SmithFred Hutch/University of Washington Cancer Consortium
Michael J Wagner, MDUniversity of Washington
Jonathan B BrickerFred Hutch/University of Washington Cancer Consortium

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Joshua A. Hill specialize in?
Joshua A. Hill focuses on Lymphoma and B-Cell Lymphoma. In particular, much of their work with Lymphoma has involved treating patients, or patients who are undergoing treatment.
Is Joshua A. Hill currently recruiting for clinical trials?
Yes, Joshua A. Hill is currently recruiting for 1 clinical trial in Seattle Washington. If you're interested in participating, you should apply.
Are there any treatments that Joshua A. Hill has studied deeply?
Yes, Joshua A. Hill has studied treatments such as Anti-CD19-targeting CAR-T Cells, Immune Globulin Infusion (Human), 10% Solution, Wistar Rabies Virus Strain PM-1503-3M Vaccine.
What is the best way to schedule an appointment with Joshua A. Hill?
Apply for one of the trials that Joshua A. Hill is conducting.
What is the office address of Joshua A. Hill?
The office of Joshua A. Hill is located at: Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington 98109 United States. This is the address for their practice at the Fred Hutch/University of Washington Cancer Consortium.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top